Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04599153
Other study ID # Dnr 2017-254-31M
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 10, 2017
Est. completion date October 28, 2021

Study information

Verified date November 2022
Source Uppsala University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized, double-blinded, cross-over study aim to evaluate the effects of shunt treatment in idiopathic normal pressure hydrocephalus (iNPH) by measuring cerebral ventricular volume and clinical symptoms at different shunt opening pressures. Further, proteins in the cerebrospinal fluid (CSF) will be compared before and after shunt surgery.


Description:

The participants are evaluated before surgery and one month, two months, three months and three months plus one day after surgery. At each evaluation point a MRI of the brain with volumetric sequences is performed and clinical data is collected (Walking speed and steps for Time up and go, 10m walking and 3m walking backwards. Mini Mental State Examination, balance, gait, self rating of incontinence, Epworth Sleepiness Scale). At surgery, all patients are given a ventriculoperitoneal (VP) shunt (Strata ® ) with an opening pressure setting of 1.5. After the first evaluation, one month postoperatively, participants are randomized to either a higher (2.5) or a lower (1.0) opening pressure, ratio 1:1. The opening pressure setting is blinded both for patients and the clinician during the subsequent clinical evaluations. At two months, the opening pressure is crossed over to the alternative setting (2.5 or 1.0). At three months, all participants receive the lowest shunt opening pressure (0.5) with the final evaluation the next day. Semiautomatic measurement of the lateral as well as the third cerebral ventricles will be performed using the MRI scans and volumetric software: SyMRI (SyntheticMR AB, Linköping, Sweden) CSF is collected at three times for each participant, from the lumbar spine pre- and 3 months postoperatively and intracranially during surgery. Further, intracranial CSF is taken through the Rickham Reservoir at the 3 months postoperative evaluation. After CSF from the participants has been collected, a single batch mass spectrometry will be performed with all the samples simultaneously. Sample size was determined to achieve 80% power for a two tailed paired t-test for a mean change in ventricular volume of 8ml, estimated from postoperative change in ventricular volume in a previous study. Hypotheses: - The volume of the ventricular system in the brain decreases significantly after shunt-surgery. - The ventricular volume is larger at high opening pressures compared to low opening pressures of the shunt. - The decrease in ventricular volume is related to clinical outcome.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date October 28, 2021
Est. primary completion date October 28, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of idiopathic normal pressure hydrocephalus and planned treatment with shunt surgery. Exclusion Criteria: - Ongoing anticoagulation treatment - Ongoing Clopidogrel treatment - Mini mental state examination results of 15 or lower. - Contraindications to magnetic resonance imaging.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ventriculoperitoneal shunt opening pressure setting
The ventriculoperitoneal shunt (Strata®) opening pressure can be changed using a magnetic tool. The possible settings are 0.5, 1.0, 1.5, 2.0, 2.5 with a higher setting number corresponding to a higher opening pressure and less drainage through the shunt. All settings are used in routine clinical practice.

Locations

Country Name City State
Sweden Neurology Clinic, Östersund Hospital Östersund Jämtland

Sponsors (1)

Lead Sponsor Collaborator
Uppsala University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ventricular volume at different shunt settings (mL) Change in ventricular volume (ml) measured by MRI Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Primary Time of "Timed Up and Go" test at different shunt settings Change in total walking time (sec) on "Timed Up and Go". Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Primary Time of 10m walking test at different shunt settings Change in total walking time (sec) on 10m walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Ventricular versus lumbar cerebrospinal fluid composition determined by mass spectrometry Change in CSF composition from ventricular versus lumbar collection sites. Quantified with mass spectrometry and statistically compared on a protein by protein basis. Cerebrospinal fluid is collected during diagnostic procedures before surgery, during surgery and three months and one day after surgery.
Secondary Change in CSF composition after surgery determined by mass spectrometry Change in CSF composition before versus after surgery. Quantified with mass spectrometry and statistically compared on a protein by protein basis. Cerebrospinal fluid is collected during diagnostic procedures before surgery, during surgery and three months and one day after surgery.
Secondary Number of steps of "Timed Up and Go" test at different shunt settings Change in number of steps on "Timed Up and Go" test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Number of steps of "Timed Up and Go" test at different time points regardless of shunt setting Change in number of steps on "Timed Up and Go" test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Number of steps on 10m walking test at different shunt settings Change in number of steps on 10m walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Number of steps on 10m walking test at different time points regardless of shunt setting Change in number of steps on 10m walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Time of 3m backwards walking test at different shunt settings Change in total walking time (sec) on 3m backwards walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Time of 3m backwards walking test at different time points regardless of shunt setting Change in total walking time (sec) on 3m backwards walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Number of steps on 3m backwards walking test at different shunt settings Change in number of steps on 3m backwards walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Number of steps on 3m backwards walking test at different time points regardless of shunt setting Change in number of steps on 3m backwards walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Mini Mental State Examination at different shunt settings Change in Mini Mental State Examination results. (min 0, max 30, higher is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Mini Mental State Examination at different time points regardless of shunt setting Change in Mini Mental State Examination results. (min 0, max 30, higher is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Epworth sleepiness scale at different time points regardless of shunt setting Change in Epworth sleepiness scale rating. (min 0, max 24, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Epworth sleepiness scale at different shunt settings Change in Epworth sleepiness scale rating. (min 0, max 24, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Continence scale at different time points regardless of shunt setting Change in continence scale rating. (min 1, max 6, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Continence scale at different shunt settings. Change in continence scale rating. (min 1, max 6, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Balance scale at different shunt settings. Change in Balance scale rating. (min 1, max 7, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Balance scale at different time points regardless of shunt setting Change in Balance scale rating. (min 1, max 7, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Modified rankin scale at different time points regardless of shunt setting Change in Modified rankin scale rating. (min 0, max 6, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Modified rankin scale at different shunt settings. Change in Modified rankin scale rating. (min 0, max 6, lower is better) Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Gray matter volume at different time points regardless of shunt setting Change in whole brain grey matter volume measured by MRI (mL). Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Gray matter volume at different shunt settings. Change in whole brain grey matter volume measured by MRI (mL). Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary White matter volume at different time points regardless of shunt setting Change in whole brain white matter volume measured by MRI (mL). Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary White matter volume at different shunt settings. Change in whole brain white matter volume measured by MRI (mL). Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Time of "Timed Up and Go" test at different time points regardless of shunt setting Change in total walking time (sec) on "Timed Up and Go". Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Time of 10m walking test at different time points regardless of shunt setting Change in total walking time (sec) on 10m walking test. Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
Secondary Ventricular volume at different time points regardless of shunt setting (mL) Change in ventricular volume (mL) measured by MRI Assessed before surgery and at one, two and, three months and three months plus one day post surgery.
See also
  Status Clinical Trial Phase
Recruiting NCT06083233 - Role of Brain Specific Biomarkers in Hydrocephalus N/A
Active, not recruiting NCT04785560 - Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus N/A
Recruiting NCT05250505 - Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus N/A
Terminated NCT03076723 - Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus N/A
Recruiting NCT04011566 - Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
Recruiting NCT04309487 - Diagnostic Accuracy of ShuntCheck Compared to Radionuclide Shunt: Patency in Patients With Normal Pressure Hydrocephalus
Completed NCT02659111 - Effects of Physical Training in iNPH N/A
Completed NCT01850914 - Vascular Risk Factors in INPH-patients N/A
Completed NCT01115270 - A Study Comparing Shunt Placement Versus Endoscopic Third Ventriculostomy in the Treatment of Hydrocephalus N/A
Completed NCT05204745 - Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten
Recruiting NCT05232838 - US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus N/A